AvKare recalled 1,512 cartons of Chlorpromazine Hydrochloride Tablets on August 25, 2025. The recall follows the discovery of a foreign substance in the medication. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Presence of a foreign substance.
Consumers and healthcare providers should stop using this product immediately. Contact AvKARE or your healthcare provider for guidance. Notification method: E-Mail
The recalled product is Chlorpromazine Hydrochloride Tablets, USP, 50 mg, 50 tablets per carton. Lot numbers include 46824 and 47171, with expiration dates of September 30, 2025, and December 31, 2025.
The presence of a foreign substance poses significant health risks. This issue falls under Class II recall, indicating a potential for serious health implications.
No specific incidents or injuries have been reported at this time. The recall was initiated due to the potential contamination risk.
Stop using the recalled tablets immediately. Contact AvKARE or your healthcare provider for further instructions.
For more information, email AvKARE or visit their website. Consumers can also find details at the FDA recall page.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.